Estrogen receptor 1 haplotype does not regulate oral contraceptive-induced changes in haemostasis and inflammation risk factors for venous and arterial thrombosis
Author(s) -
Moniek P.M. de Maat,
ElseMarie Bladbjerg,
Cornelis Kluft,
Ulrich Winkler,
Hans Rekers,
Sven O. Skouby,
Jørgen Jespersen
Publication year - 2006
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/del015
Subject(s) - haplotype , estrogen , venous thrombosis , thrombosis , estrogen receptor , medicine , endocrinology , plasminogen activator inhibitor 1 , plasminogen activator , genotype , biology , genetics , gene , breast cancer , cancer
Administration of oral contraceptives (OCs) has profound effects on the plasma levels of haemostasis and inflammation variables, resulting in an increased thrombosis risk. Individuals show large differences in the response of these variables to OCs. Polymorphism in the estrogen receptor-1 (ER1) gene may explain part of this inter-individual response.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom